Literature DB >> 825338

Schistosoma mansoni in baboons. Antibody-dependent cell-mediated damage to 51Cr-labelled schistosomula.

A E Butterworth, R F Sturrock, V Houba, R Taylor.   

Abstract

A technique is described for estimating cell-mediated damage to the larval stages of Schistosoma mansoni that occur in the mamalian host (schistosomula), by measuring release of 51Cr from labelled organisms. This technique, although widely used for assaying cytotoxicity to single cell suspensions or monolayers, has not previously been applied to a multicellular parasite. It is more objective than microscopical assays, and allows the processing of larger numbers of samples. The new method has been used for the detection and quantification of cell-dependent cytotoxic antibodies in infected baboons. The effector cell in normal baboon peripheral blood, as in man, is associated with a neutrophil- and eosinophil-enriched fraction. Cytotoxic antibodies appear in the serum about 4 weeks after a primary infection, rising to a peak at 7-10 weeks, and then declining. In some animals, a second rise towards 30 weeks was observed. There were no consistent differences between groups of baboons exposed to 1000 cercariae, 200 cercariae, and 200 cercariae administered at each of five monthly intervals. The possible relationship between cell-dependent cytotoxic antibodies and resistance to reinfection in infected animals is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825338      PMCID: PMC1541391     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Antibody-dependent cell-mediated damage to schistosomula in vitro.

Authors:  A E Butterworth; R F Sturrock; V Houba; P H Rees
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

2.  Host antigens in schistosomiasis.

Authors:  S R Smithers; R J Terry; D J Hockley
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-02-25

3.  Combined in vitro effects of rat antibody and neutrophilic leukocytes on schistosomula of Schistosoma mansoni.

Authors:  D A Dean; R Wistar; K D Murrell
Journal:  Am J Trop Med Hyg       Date:  1974-05       Impact factor: 2.345

4.  The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes.

Authors:  I C MacLennan; G Loewi; B Harding
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

5.  Letter: Damage to schistosomula of Schistosoma haematobium in vitro by immune baboon and human sera and absence of cross-reaction with Schistosoma mansoni.

Authors:  M Smith; G Webbe
Journal:  Trans R Soc Trop Med Hyg       Date:  1974       Impact factor: 2.184

6.  The effects of immune rhesus monkey serum on schistosomula of Schistosoma mansoni during cultivation in vitro.

Authors:  J A Clegg; S R Smithers
Journal:  Int J Parasitol       Date:  1972-03       Impact factor: 3.981

7.  Partial isolation of a membrane antigen which induces the formation of antibodies lethal to schistosomes cultured in vitro.

Authors:  A Sher; J R Kusel; H Perez; J A Clegg
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

8.  Immunity in schistosomiasis.

Authors:  S R Smithers; R J Terry
Journal:  Ann N Y Acad Sci       Date:  1969-10-06       Impact factor: 5.691

9.  [Hypersensitivity in human schistosomiasis due to Schistosoma mansoni and Schistosoma haematobium. II. In vitro study of the lethal activity of patient sera for schistosomules of S. mansoni. Relation to hypersensitivity tests].

Authors:  A Capron; M Capron; D Camus; A Vernes
Journal:  Pathol Biol (Paris)       Date:  1973-12

10.  Studies on heterologous immunity in schistosomiasis. 7. Observations on the development of acquired homologous and heterologous immunity to Schistosoma mansoni in baboons.

Authors:  M G Taylor; G S Nelson; M Smith; B J Andrews
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

View more
  8 in total

1.  Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice.

Authors:  A A Mahmoud; M K Stone; R W Kellermeyer
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

2.  The modulation of specific and non-specific cell-mediated immunity in baboons (Papio anubis) infected with Schistosoma mansoni.

Authors:  B J Cottrell; R F Sturrock
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

3.  IgE-dependent cellular adhesion and cytotoxicity to Litomosoides carinii microfilariae--nature of effector cells.

Authors:  K Mehta; R K Sindhu; D Subrahmanyam; K Hopper; D S Nelson
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

4.  Cytotoxicity of human and baboon mononuclear phagocytes against schistosomula in vitro: induction by immune complexes containing IgE and Schistosoma mansoni antigens.

Authors:  M Joseph; A Capron; A E Butterworth; R F Sturrock; V Houba
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

5.  Transformation induced by Echinococcus granulosus protoscoleces in unprimed murine spleen cells: identity and MHC restriction of participating cell types.

Authors:  D A Cox; J B Dixon; S Marshall-Clarke
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

6.  Kidney lesions in baboons infected with Schistosoma mansoni.

Authors:  V Houba; R F Sturrock; A E Butterworth
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

Review 7.  Glycoconjugates in host-helminth interactions.

Authors:  Nina Salinger Prasanphanich; Megan L Mickum; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Front Immunol       Date:  2013-08-28       Impact factor: 7.561

8.  Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils.

Authors:  A E Butterworth; J R David; D Franks; A A Mahmoud; P H David; R F Sturrock; V Houba
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.